Drug companies will collectively pay an extra $100 million in annual membership dues to industry group Pharmaceutical Research and Manufacturers of America (PhRMA).

Precision biomarkers have been shown to be an effective tool in cancer care, but most evidence comes from clinical trials rather than real patient experiences. Christopher Friese, PhD, RN, of the University of Michigan School of Nursing in Ann Arbor, and colleagues are testing how practicing physicians are using a 21-gene recurrence score (RS) biomarker test in breast cancer patients.

Preparing patients before surgical procedures with enhanced recovery after surgery (ERAS) programs boosts patient knowledge while reducing recuperation time and decreasing necessary drug intervention, according to the results shown at two different healthcare facilities.

Sysmex Canada, providers of automated hematology and urinalysis diagnostic testing, has launched the new XN-L Series for testing in smaller analytic devices.

Attempts to publicly shame hospitals which have substantially increased prices don't appear to work.

Casamba announced the company has merged with HealthWyse of Boston and TherapySource of Birmingham, Alabama.

Sparta Systems, Inc., a producer of enterprise quality management software (EQMS) solutions, has launched its cloud-based Stratas Quality Management solution.

In eight states, insurance regulators approved increases in health insurance premiums for Affordable Care Act exchange plans above what companies asked for, according to an analysis in USA Today.